赛伦生物
(688163)
| 流通市值：42.21亿 | | | 总市值：42.21亿 |
| 流通股本：1.08亿 | | | 总股本：1.08亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 52,641,806.22 | 33,284,505.89 | 74,948,031.35 | 133,341,233.87 |
| 交易性金融资产 | 712,149,071.23 | 764,909,182.18 | 711,297,780.82 | 611,868,602.74 |
| 应收票据及应收账款 | 55,440,604.59 | 46,098,142.29 | 77,806,092.94 | 98,582,846.11 |
| 其中：应收票据 | 6,256,927.8 | 10,036,552.63 | 12,626,216.34 | - |
| 应收账款 | 49,183,676.79 | 36,061,589.66 | 65,179,876.6 | 98,582,846.11 |
| 预付款项 | 79,285 | 87,156.35 | 1,027,208.02 | 128,500 |
| 其他应收款合计 | 1,235,867.96 | 902,207.94 | 1,070,170.45 | 978,192.93 |
| 存货 | 46,045,202.74 | 43,031,117.28 | 38,759,460 | 42,405,191.16 |
| 一年内到期的非流动资产 | 11,700,000 | 11,700,000 | - | - |
| 其他流动资产 | 12,080,712.9 | 12,149,399.6 | 12,601,247.24 | 20,597,899.56 |
| 流动资产合计 | 891,372,550.64 | 912,161,711.53 | 917,509,990.82 | 907,902,466.37 |
| 非流动资产: | | | | |
| 固定资产 | 108,614,931.59 | 111,983,906.37 | 114,577,515.78 | 104,488,670.43 |
| 在建工程 | 101,736,965.57 | 80,988,836.96 | 70,180,938.94 | 63,653,512.88 |
| 生产性生物资产 | 3,599,520.09 | 3,577,499.93 | 3,708,003.57 | 2,996,024.52 |
| 使用权资产 | 4,140,942.32 | 4,409,384.14 | 3,395,117.2 | 3,474,073.39 |
| 无形资产 | 22,277,649.56 | 22,472,538.8 | 22,667,428.04 | 22,862,317.28 |
| 长期待摊费用 | 334,717.41 | 394,704.15 | 454,690.89 | 514,677.63 |
| 递延所得税资产 | 7,381,326.31 | 6,885,710.68 | 8,065,850.1 | 8,541,275.49 |
| 其他非流动资产 | 14,913,607.45 | 14,336,114.68 | 20,974,500 | 21,094,954.85 |
| 非流动资产合计 | 262,999,660.3 | 245,048,695.71 | 244,024,044.52 | 227,625,506.47 |
| 资产总计 | 1,154,372,210.94 | 1,157,210,407.24 | 1,161,534,035.34 | 1,135,527,972.84 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 17,061,317.39 | 16,493,570.2 | 10,879,814.14 | 1,888,452.95 |
| 应付账款 | 17,061,317.39 | 16,493,570.2 | 10,879,814.14 | 1,888,452.95 |
| 合同负债 | 3,522,625.81 | 3,183,692.52 | 2,915,190.56 | 3,729,443.79 |
| 应付职工薪酬 | 8,153,343.9 | 11,533,685.2 | 6,402,637.65 | 4,873,189.22 |
| 应交税费 | 1,054,805.85 | 632,974.37 | 7,166,256.22 | 7,911,037.06 |
| 其他应付款合计 | 3,210,604.09 | 4,201,532.38 | 4,190,476.66 | 5,116,942.53 |
| 应付股利 | 22,900 | 22,900 | 22,900 | 21,700 |
| 一年内到期的非流动负债 | 767,626.86 | 767,626.86 | 309,157.83 | 309,157.83 |
| 其他流动负债 | - | 94,053.07 | 87,455.71 | 155,744.64 |
| 流动负债合计 | 33,770,323.9 | 36,907,134.6 | 31,950,988.77 | 23,983,968.02 |
| 非流动负债: | | | | |
| 租赁负债 | 4,176,440.31 | 4,327,823.52 | 3,653,402.71 | 3,842,144.35 |
| 预计负债 | 2,039,654.91 | 2,039,654.91 | - | - |
| 递延所得税负债 | 1,161,010.4 | 1,278,188.94 | 848,780.3 | 868,518.35 |
| 非流动负债合计 | 7,377,105.62 | 7,645,667.37 | 4,502,183.01 | 4,710,662.7 |
| 负债合计 | 41,147,429.52 | 44,552,801.97 | 36,453,171.78 | 28,694,630.72 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,220,000 | 108,220,000 | 108,220,000 | 108,220,000 |
| 资本公积 | 878,087,814.86 | 878,087,814.86 | 878,087,814.86 | 878,087,814.86 |
| 盈余公积 | 54,628,047.79 | 54,628,047.79 | 51,677,171.45 | 51,677,171.45 |
| 未分配利润 | 72,288,918.77 | 71,721,742.62 | 87,095,877.25 | 68,848,355.81 |
| 归属于母公司股东权益合计 | 1,113,224,781.42 | 1,112,657,605.27 | 1,125,080,863.56 | 1,106,833,342.12 |
| 股东权益合计 | 1,113,224,781.42 | 1,112,657,605.27 | 1,125,080,863.56 | 1,106,833,342.12 |
| 负债和股东权益合计 | 1,154,372,210.94 | 1,157,210,407.24 | 1,161,534,035.34 | 1,135,527,972.84 |
| 公告日期 | 2026-04-25 | 2026-04-25 | 2025-10-28 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |